The US Food and Drug Administration wants to be more understanding of advisory committee members’ professional lives as part of its ongoing effort to reform the system.
Principal Deputy Commissioner Namandjé Bumpus said on 13 March that the FDA wants to make the process of serving on...
Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?